Newsroom
Category
March 3, 2025
San Antonio has one of the highest rates of metabolic dysfunction-associated steatotic liver disease (MASLD) in the United States, largely driven by high rates of obesity and diabetes in the region. This chronic liver condition can lead to serious health conditions including severe liver fibrosis or cirrhosis and liver cancer, posing a significant public health […]
February 27, 2025
Researchers at The University of Texas Health Science Center at San Antonio and their collaborators at Emory University have received a $4.9 million grant aimed at significantly improving treatment and recovery rates for individuals suffering from post-traumatic stress disorder.
February 27, 2025
The University of Texas Health Science Center at San Antonio (UT Health San Antonio) received more than $3.19 million in new academic research awards as part of the latest $68 million funding round announced on February 19 by the Cancer Research Prevention Institute of Texas (CPRIT). The state agency, which focuses on the fight […]
February 26, 2025
Landmark ‘Nun Study’ initiative now housed at Biggs Institute Catholic nuns don’t make a habit of participating in long-term studies on aging and dementia, but one notable exception has yielded critical insights into cognitive resilience, neuropathology and aging-related disorders. Researchers at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) published a […]
February 25, 2025
The American Society for Gastrointestinal Endoscopy (ASGE) recently announced that Prabhleen Chahal, MD, FASGE, FACG, the Steven Schenker Distinguished Professor in Medicine (Tenure) and chief of the Division of Gastroenterology and Human Nutrition in the Joe R. and Teresa Lozano Long School of Medicine at The University of Texas Health Science Center at San Antonio […]
February 21, 2025
Despite advances in cancer treatment in recent years, five-year survival rates for acute myeloid leukemia (AML) remain low at just 30% on average, according to the National Cancer Institute. Factors in the development of AML are diverse with many different drivers. A longtime goal for scientists in this field is finding a single drug that can treat all types of AML.